First pediatric B-acute lymphoblastic leukemia patient treated with anti-CD19 chimeric antigen receptor T-cell therapy: Long-term remission or early cure?

• Dimitrios Bouzianas,
• Stella Bouziana

Affiliations

Dimitrios Bouzianas

BReMeL, Biopharmaceutical and Regenerative Medicine Laboratories, Thessaloniki, Greece

Stella Bouziana

Department of Hematology, King’s College Hospital, London, UK